试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-06-26
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors
编号:NCT03685591登记状态:提前终止企业 / 申办者:Pfizer
药物 / 成分:PF-06952229、Enzalutamide
登记的停止原因(原文):The decision to stop enrollment was due to strategic considerations and not due to any specific safety reasons or request from a regulatory authority.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-06-26
Differential Efficacy of Corticosteroid Solutions for Non-Operative Treatment of Digit Flexor Tenosynovitis
编号:NCT04002037登记状态:提前终止企业 / 申办者:University of Missouri-Columbia
药物 / 成分:Triamcinolone Acetonide 40mg/mL、Triamcinolone Acetonide 10mg/mL、Dexamethasone 4 mg/ml
登记的停止原因(原文):Preliminary analysis revealed no difference
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-06-26
A Dose-Range Finding Clinical Trial Study in Human Immunodeficiency Virus (HIV-1) Infected Treatment-Naive Adults
编号:NCT04493216登记状态:提前终止企业 / 申办者:ViiV Healthcare
药物 / 成分:GSK3640254、ABC/3TC、FTC/TAF、Dolutegravir
登记的停止原因(原文):Company decision to stop compound development. The decision is not based on any safety or efficacy concerns. It reflects the company strategy for portfolio progression.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-06-26
Evaluating Postoperative Non-Opioid Pain Management Utilizing Local Anesthetics Coupled With Modulated Coagulation
编号:NCT04814433登记状态:提前终止企业 / 申办者:NYU Langone Health
药物 / 成分:Tranexamic acid、Aminocaproic acid、Recombinant Human Thrombin、Lidocaine Hydrochloride with Epinephrine
登记的停止原因(原文):Both lack of enrollment as well as study staff turnover
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-06-26
A Study to Assess if BIIB122 Tablets Are Safe and Can Slow Worsening of Early-Stage Parkinson's Disease in Participants With Specific LRRK2 Genetic Variants Between the Ages of 30 and 80 Using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale
编号:NCT05418673登记状态:提前终止企业 / 申办者:Biogen
药物 / 成分:BIIB122、BIIB122-Matching Placebo
登记的停止原因(原文):Sponsor Decision
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-06-25
MRSA Eradication and Decolonization in Children
编号:NCT02127658登记状态:提前终止企业 / 申办者:Indiana University
药物 / 成分:Hygiene education、Sodium Hypochlorite、Mupirocin ointment
登记的停止原因(原文):Unable to recruit all planned participants prior to end of funding
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-06-25
Treatment of ppROM With Erythromycin vs. Azithromycin Trial
编号:NCT03060473登记状态:提前终止企业 / 申办者:The University of Texas Medical Branch, Galveston
药物 / 成分:Azithromycin、Erythromycin、Ampicillin、Amoxicillin
登记的停止原因(原文):Patient population that meets study criteria is insufficient to continue project in a reasonable amount of time. To continue is futile in resources, staff time, and effort.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-06-25
A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma
编号:NCT03905889登记状态:提前终止企业 / 申办者:Brown University
药物 / 成分:Abemaciclib、Sunitinib
登记的停止原因(原文):Funding withdrawn
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-06-25
Study of Poziotinib in Japanese Patients With NSCLC
编号:NCT04402008登记状态:提前终止企业 / 申办者:Spectrum Pharmaceuticals, Inc
药物 / 成分:Poziotinib Once Daily Dosing、Poziotinib Twice Daily Dosing、Poziotinib Once Daily Dosing or Twice Daily Dosing as determined in Phase 1
登记的停止原因(原文):Business decision, not related to safety.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-06-25
Phase I Study of the BBP-398 in Patients With Advance Solid Tumors
编号:NCT05621525登记状态:提前终止企业 / 申办者:LianBio LLC
药物 / 成分:BBP-398
登记的停止原因(原文):Business reason
查看官方原始记录 ↗